




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Acute Coronary Syndromes</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=332172f7-e818-41a0-976e-9ab92513cae5</link>
        <description>Clinical Topic Feed: Acute Coronary Syndromes</description>
        <language>en</language>

        

                <item>
                    <title>AI-Enabled Clinician: Patient Engagement and Care Transformation with AI-Quantified Plaque Analysis</title>
<link>/Latest-in-Cardiology/Articles/2026/05/07/15/36/ai-enabled-clinician-07may2026</link>                    <description>In this episode, Chief Innovation Officer, Ami Bhatt, MD, FACC and Allen Taylor, MD, FACC discuss the importance of cardiovascular prevention and early screening through AI-quantified plaque analysis by drawing parallels to how oncology and gastroenterology approach early detection.</description>
                    <pubdate>1778168340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For May 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1777629480000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC.26 Coronary Interventional Trials</title>
<link>/Latest-in-Cardiology/Articles/2026/04/27/19/07/ACC26-Coronary-Interventional-Trials</link>                    <description>Late-breaking clinical trials presented at ACC.26 focusing on coronary interventions included several looking at intravascular guidance in complex, high-risk procedures (IVUS-CHIP), bifurcation lesions (DKCRUSH VIII), and unprotected left main PCI (OPTIMAL).</description>
                    <pubdate>1777570260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AI-Enabled Clinician: Engaging the Physician Community Around AI-Quantified Plaque Analysis Technology</title>
<link>/Latest-in-Cardiology/Articles/2026/04/09/13/37/ai-enabled-clinician-09apr2026</link>                    <description>In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt speaks with Dr. Todd Villines about the transformative role of AI-enabled coronary CT angiogram (CCTA) and how it is expanding patient access to essential coronary artery disease (CAD) diagnostics.</description>
                    <pubdate>1775748600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HOST-EXAM: Clopidogrel vs. Aspirin Monotherapy at 10 Years Post PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/04/07/19/53/host-exam-acc-2026</link>                    <description>Clopidogrel monotherapy after PCI was associated with a significantly lower composite risk of all-cause death, nonfatal MI, stroke, readmission for acute coronary syndrome (ACS) and major bleeding compared with aspirin monotherapy, according to 10-year follow-up results of the HOST-EXAM trial presented as featured clinical research at ACC.26 and published simultaneously in The Lancet.</description>
                    <pubdate>1775593440000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FAST III: Novel Minimally Invasive vFFR Noninferior to FFR For Revascularization</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026</link>                    <description>Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: New ACC/AHA Dyslipidemia Guidelines Released</title>
<link>/Latest-in-Cardiology/Articles/2026/03/18/00/50/eagles-eye-view-18mar2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life.</description>
                    <pubdate>1773842400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Pre-Hospital Glycoprotein IIb/IIIa Inhibition With Zalunfiban in STEMI</title>
<link>/Latest-in-Cardiology/Articles/2026/03/16/16/27/Pre-Hospital-Glycoprotein-IIb-IIIa-Inhibition-With-Zalunfiban-in-STEMI</link>                    <description>The CELEBRATE (CeleCor Blinded Randomized Trial in ST-Elevation Myocardial Infarction) trial was a phase 3, multicenter, double-blind, placebo-controlled study that evaluated the efficacy and safety of a single subcutaneous injection of zalunfiban (CeleCor Therapeutics), a novel glycoprotein IIb/IIIa inhibitor...</description>
                    <pubdate>1773751800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Beta-Blocker vs. Calcium-Channel Blocker in HCM </title>
<link>/Latest-in-Cardiology/Articles/2026/03/11/16/14/eagles-eye-view-11mar2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at the differential effect of bisoprolol versus verapamil in nonobstructive hypertrophic cardiomyopathy (HCM) treatment.</description>
                    <pubdate>1773245700000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>RENOVATE-COMPLEX-PCI: Benefit With Intravascular Imaging Guidance Maintained at 5 Years</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/03/10/16/54/RENOVATE-COMPLEX-PCI-Benefit-With-Intravascular</link>                    <description>In the multicenter open-label superiority trial, Joo Myung Lee, MD, MPH, PhD, FACC, et al., randomized 1,639 patients (mean age 66; 20% women) with complex coronary artery lesions across 20 hospitals in South Korea 2:1 to either intravascular imaging-guided PCI (n=1,092) or angiography-guided PCI (n=547). Of the overall cohort, 49% presented with stable ischemic heart disease and 51% with an acute coronary syndrome (ACS). Thirty-one percent had three or more characteristics of complex coronary artery lesions in the target lesion. The most common was long coronary lesion, followed by multivessel PCI, true bifurcation lesion and chronic total occlusion.</description>
                    <pubdate>1773162180000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>